Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 3, 1996, Pages 287-292

  Kinnunen, Urpo ^a   Syrjälä, Hannu ^a   Koskela, Markku ^a   Kujala, Pekka ^a   Koistinen, Pirjo ^a,b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL ARTICLE; FEMALE; FEVER; FINLAND; HUMAN; HUMAN CELL; MALE; NEUTROPENIA; NONHUMAN; SCREENING;

EID: 0029782972     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027175     Document Type: Article

References (34)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328-340, 1966.
2. Feld R. The compromised host. Eur J Cancer Clin Oncol 25 (Suppl 2) 1-7, 1989.
3. Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, The Working Committee, Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161: 381-396, 1990.
4. Bodey GP, Buckley M, Satha YS, Freireich EJ. Quantitative relationships between cicrulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328-340, 1966.
5. Gurwith MJ, Brunton JL, Lank BA, Ronald AR, Harding GKM. Granulocytopenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am J Med 64: 121-126, 1978.
6. Klastersky J, Zinner SH, Calandra T, Gaya H, Glauser MP, Meunier F, Rossi M, Schimpff SC, Tattershall M, Viscoli C, The EORTC. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 24 (Suppl 1) 35-45, 1988.
7. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328: 1323-1332, 1993.
8. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 26: 77-84, 1994.
9. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amicasin and ceftriaxone versus multiple daily doses of amicasin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 119: 584-593, 1993.
10. Klastersky J. Empiric treatment of infections in neutropenic patients with cancer. Rev Infect Dis 5 (Suppl 2) 21-31, 1983.
11. Pizzo PA, Hathorm JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin M, Skeleton J, Thaler M, Wesley R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315: 552-558, 1986.
12. Lieschke GH, Bell D, Rawlinson W, Green MD, Sheridan W, Morstyn G. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview. Eur J Cancer Clin Oncol 25 (Suppl 2) 37-42, 1989.
13. Hirotsu T, Akatsuka J. Infectious complications in childhood leukemia. Acta Paediatr. Jpn 33: 564-572, 1991.
14. Bodet CA 3d, Jorgensen JH, Drutz DJ. Antibacterial activities of antineoplastic agents. Antimicrob Agents Chemother 2: 437-439, 1985.
15. Bennet JM, Catowsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HD, Sultan C. Proposals for the classification of acute leukemias. Br J Haematol 33: 451-458, 1976.
16. Elonen E, for the Finnish Leukaemia Group. Intensive chemotherapy of adult acute myelogenous leukemia: a randomized trial between 4 and 8 cycles. Blood 82 (Suppl 1) 328a, 1993.
17. Thorpe TC, Wilson ML, Turner JE, DiGuiseppi JL, Willert M, Mirrett S, Reller B. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol 28: 1608-1612, 1990.
18. Schoefield KP, Voulgari F, Gozzard DI, Leyland MJ, Beeching NJ, Stuart J. C-Reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol 35: 866-869, 1982.
19. Timonen TTT, Koistinen P. C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia. Eur J Cancer Clin Oncol 21: 557-562, 1985.
20. Santolaya ME, Cofre J, Beresi V. C-Reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 18: 589-595, 1994.
21. Kostiala AAI, Kostiala I, Valtonen VV, Teerenhovi L. Levels of C-reactive protein in patients with hematologic malignancies. Scand J Infect Dis 17: 407-410, 1985.
22. Riikonen P. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 10: 918-923, 1991.
23. Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol 32: 2103-2106, 1994.
24. Smith-Elkes S, Weinstein MP. Blood cultures. Infect Dis Clin North Am 7: 221-234, 1993.
25. Li J, Plorde JJ, Carlson LG. Effects of volume and periodicity on blood cultures. J Clin Microbiol 32: 2829-2831, 1994.
26. Pfaller MA, Sibley TK, Westfall LJ, Hoppe-Bauer JE, Keating MA, Murray PR. Clinical laboratory comparison of a slide blood culture system with a conventional broth system. J Clin Microbiol 16: 525-530, 1982.
27. Weinstein MP, Reller LB, Mirett S, Wang W-LL, Alcid DV. Controlled evaluation of Trypticase soy broth in agar slide and conventional blood culture systems. J Clin Microbiol 21: 626-629, 1985.
28. Hansen SL, Hetmanski J, Stwart BJ. Resinsprocess methods for improved isolation of organisms from blood and other body fluids. Am J Med 75: 31-36, 1983.
29. Wright AJ, Thompson RL, McLimans CA, Wilson WR, Washington II JA. The antimicrobial removal device: a microbiological and clinical evaluation. Am J Clin Pathol 78: 173-177, 1982.
30. Wilson W, Weinstein M, Mirrett S, Reimer LG, Reller LB. Controlled comparison of The Bact/Alert and BACTEC 660/ 730 nonradiometric blood culture systems. J Clin Microbiol 30: 323-329, 1992.
31. Krisher KK, Whyburn DR, Koepnick FE. Comparison of the BacT/Alert pediatric blood culture system, Pedi-BacT, with conventional culture using the 20-milliliter Becton-Dickinson supplemented peptone broth tube. J Clin Microbiol 31: 793-797, 1993.
32. Nolte FS, Williams JM, Jerris RC, Morello JA, Leitch CD, Matushek S, Schwabe LD, Dorigan F, Kocka FE. Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J Clin Microbiol 31: 552-557, 1993.
33. Zwadyk P, Pierson CL, Young C. Comparison of Difco ESP and Organon Teknika BacT/Alert continuous-monitoring blood culture systems. J Clin Microbiol 32: 1273-1279, 1994.
34. Kern W, Kirchner S, Vanek E. Resin versus standard blood culture media used with the new BACTEC automated infrared system: an evaluation in febrile granulocytopenic patients. W Int J Med Microbiol 273: 156-163, 1990.